Merck Sharp and Dohme launches new Biosimilars Clarified website

Merck Sharp and Dohme has announced the launch of a new educational website providing information on biosimilar medicines for patients, caregivers and the healthcare community.

The Biosimilars Clarified website is designed to provide clear, concise and straightforward information about biosimilars in a simple, easy-to-use question-and-answer format, reflecting the growing importance of these therapies in global health.

Questions that the website will address include basic queries about what biosimilars are and whether they are safe and effective, as well as details on the value they can provide and the availability of support programmes for patients taking these therapies.

Dora Bibila, general manager for Merck Biosimilars, said: "We believe the more patients know, the more they can be in charge of their health – Biosimilars Clarified is designed to help answer their questions about biosimilars."

A number of biosimilars have already been approved by regulators in the EU and US, offering cost-effective alternatives to biologic therapies with no clinically meaningful differences in terms of the safety, purity and potency of the products.

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.